Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.
- DOI
- 10.1016/j.ahj.2025.03.003
- Published
- 2025 Aug
- Container
- American heart journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2025.03.003,
title = {Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.},
author = {Marston NA and Bergmark BA and Alexander VJ and Karwatowska-Prokopczuk E and Kang YM and Moura FA and Prohaska TA and Zimerman A and Zhang S and Murphy SA and Tsimikas S and Giugliano RP and Sabatine MS},
year = {2025},
journal = {American heart journal},
doi = {10.1016/j.ahj.2025.03.003},
url = {https://doi.org/10.1016/j.ahj.2025.03.003}
}RIS
TY - JOUR TI - Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. AU - Marston NA AU - Bergmark BA AU - Alexander VJ AU - Karwatowska-Prokopczuk E AU - Kang YM AU - Moura FA AU - Prohaska TA AU - Zimerman A AU - Zhang S AU - Murphy SA AU - Tsimikas S AU - Giugliano RP AU - Sabatine MS PY - 2025 JO - American heart journal DO - 10.1016/j.ahj.2025.03.003 UR - https://doi.org/10.1016/j.ahj.2025.03.003 ER -
APA
NA, M., BA, B., VJ, A., E, K., YM, K., FA, M., TA, P., A, Z., S, Z., SA, M., S, T., RP, G., & MS, S. (2025). Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.. American heart journal. https://doi.org/10.1016/j.ahj.2025.03.003
Source records
- pubmed · retrieved 2026-09-25T16:28:32.763Z